A state-by-state breakdown of Testosterone Enanthate Medicaid coverage tiers, prior authorization rules, step therapy requirements, and practical strategies to lower your out-of-pocket cost in 2026.
A guide to compassionate use, expanded access, manufacturer assistance programs, HSA/FSA eligibility, and discount strategies for vaginal estradiol in 2026.
A guide to the legal, regulatory, and cost field for purchasing vaginal estradiol internationally, including FDA rules, cross-border import policies, HSA/FSA eligibility, and legitimate discount pathways.
A week-by-week clinical breakdown of progesterone-related sedation: when it starts, when it peaks, when it resolves, and what the trial data show. Includes dosing strategies, red flags, and patient FAQs.
A guide to oral estradiol use in women aged 65 and older, covering cognitive function, physical activity, fall risk, driving, and continuing education, with primary-source citations throughout.
A clinical guide to oral estradiol dosing, safety monitoring, and care transitions for patients aged 65 and older, reviewed by board-certified physicians.
A guide for adults 65+ using estradiol transdermal patches: how patch use affects physical activity, cognitive engagement, fall risk, and daily routines, with dosing, safety data, and practical clinical guidance.
A clinical guide to oral micronized progesterone (Prometrium) for patients 65 and older transitioning to adult care, covering dosing, safety, fall risk, and monitoring.
A clinician-level review of how AndroGel (testosterone gel 1% and 1.62%) affects scalp hair, body hair, sebum production, acne, and skin thickness, with primary-literature citations and practical management guidance.
How AndroGel (testosterone gel 1% and 1.62%) affects sleep quality, sleep architecture, and sleep-disordered breathing in men with hypogonadism, and how to decide whether pre-treatment sleep apnea screening is needed.
A guide to how Armour Thyroid (natural desiccated thyroid) affects hair loss, hair regrowth, skin texture, and dryness, with primary-literature citations, real doses, and clinical decision frameworks.
FDA-approved oxandrolone dosing is 2.5-20mg/day. Covers liver enzyme changes, lipid effects, testosterone suppression, and monitoring needs from clinical data.
A clinical review of Women's International Pharmacy's prescription intake process, compounded bioidentical hormone therapy offerings, costs, legitimacy, and how it stacks up against alternatives.
A prescriber-level monograph covering every FDA-approved testosterone formulation: pharmacokinetics, dosing, monitoring, adverse effects, and clinical decision frameworks for hypogonadism management.
A prescriber-level guide to levothyroxine dose titration, tapering, and monitoring. Covers starting doses, adjustment intervals, special populations, and evidence-based TSH targets from ATA and AACE guidelines.
A clinical comparison of enclomiphene citrate and Jatenzo (oral testosterone undecanoate) for male hypogonadism, including how and when to switch between them, with primary-source citations throughout.
A detailed clinical comparison of testosterone enanthate injections versus AndroGel (testosterone gel 1.62%) side-effect profiles, dosing, transfer risk, and which format suits different patients.
Learn which menopause-related symptoms are true medical emergencies requiring 911, how to distinguish them from typical hot flashes and palpitations, and what treatments reduce long-term cardiovascular and bone risk.
A guide to stopping HRT and menopausal hormone therapy safely, including tapering schedules, symptom management, bone protection strategies, and major society guidelines.
A clinical timeline of menopause treatment from the 1940s to today, covering estrogen therapy, the WHI trial, and current hormone and non-hormone options with guideline-based guidance.
An evidence-based overview of how common menopause-related weight gain is worldwide, which populations are most affected, and what the data say about body composition shifts during the menopausal transition.
Learn how to stop perimenopause treatments safely, including HRT, low-dose oral contraceptives, and non-hormonal therapies. Evidence-based tapering protocols, withdrawal timelines, and society guideline recommendations.
Perimenopause is misdiagnosed as depression, thyroid disease, anxiety, ADHD, and more. Learn which conditions get confused, why labs mislead, and how to get the right diagnosis.
A look at how many people experience menopause worldwide, regional age-at-menopause differences, rising life-expectancy implications, and what epidemiological trends mean for treatment planning.
A deep dive into how testosterone replacement therapy changes liver glucose output, insulin sensitivity, and cardiometabolic risk markers, with trial data and dosing context.
Menopause does not directly cause type 2 diabetes, but the hormonal shifts it triggers, falling estrogen, rising visceral fat, worsening insulin resistance, meaningfully raise a woman's risk. Learn what the evidence shows, which women are most at risk, and what you can do about it.
A guide to oral estradiol tablet dosing for adults aged 30 to 49, covering starting doses, titration, progestogen co-therapy, safety monitoring, and where the evidence is solid versus where individualized judgment is required.
A guide to oral estradiol safety for adults aged 30 to 49, covering cardiovascular risk, clot risk, breast cancer data, dosing, monitoring, and when transdermal estradiol is the better route.
A clinician-level review of oral estradiol use in patients with autoimmune conditions, covering disease-specific risks, pharmacokinetics, guideline positions, and practical prescribing decisions.
A clinical guide to oral estradiol dosing in the 50, 64 age group, covering starting doses, titration, cardiovascular risk stratification, WHI trial context, and current guideline recommendations.
A clinically detailed review of oral estradiol safety for adults ages 50 to 64, covering cardiovascular risk, VTE, breast cancer, bone effects, drug interactions, and how the timing hypothesis reshapes prescribing decisions in this age group.
A clinician-level guide to switching oral estradiol to or from transdermal, vaginal, and injectable estrogen formulations, with dosing equivalencies, symptom-bridging protocols, and safety checkpoints backed by primary trial data.
A clinical guide to adjusting oral estradiol dosing schedules during long-haul travel, timezone crossings, and schedule disruptions. Covers PK rationale, practical timing windows, and when to contact your prescriber.
A GRADE-graded review of the clinical evidence for estradiol transdermal patches: vasomotor symptom relief, cardiovascular safety, bone protection, breast cancer risk, and route-of-administration differences. MD/PharmD-level depth with primary-literature citations.
A week-by-week guide to your first month on the estradiol transdermal patch, covering symptom timelines, serum levels, side-effect windows, and when to call your prescriber.
A guide to how transdermal estradiol affects hair growth, hair loss, skin thickness, collagen, and wound healing, with primary-literature citations and clinical dosing guidance.
A clinician-level review of how transdermal estradiol affects depression, anxiety, cognition, and mood across perimenopause and postmenopause, with primary-literature citations and prescribing guidance.
Why your estradiol patch stops working, what labs to check, how to adjust dose or delivery, and when to switch to a different HRT formulation. MD/PharmD-level guidance with primary literature.
Evidence-based guidance on when and how to restart transdermal estradiol after acute illness, including timing, dose considerations, thrombosis risk, and monitoring. Written for patients and pending qualified physician review.
Evidence-based guidance on when and how to pause estradiol transdermal therapy before surgery, including VTE risk data, anesthesia interactions, and restart protocols.
A physician-level review of how transdermal estradiol affects sexual function in postmenopausal women, covering libido, vaginal health, dyspareunia, and key trial data including the WHI Estrogen-Alone study.
A guide to estradiol transdermal monitoring in women aged 18, 29, covering lab schedules, symptom tracking, fertility planning, and safety benchmarks.
A clinical evidence review of how East Asian pharmacogenomics, body-composition norms, and androgen-receptor biology may affect testosterone cypionate dosing, monitoring, and safety discussions, with an explicit map of what is established versus extrapolated.
A clinical deep-dive into vaginal estradiol pharmacogenomics, ethnicity-stratified trial data, and practical dose-adjustment considerations for Black and African ancestry patients, prepared by the HealthRX.com Editorial Team.
Does oral estradiol interact with anesthesia? Learn the evidence-based perioperative risks, when to stop estradiol before surgery, and how to talk to your surgical team.
A guide to the interaction between oral estradiol and iodinated or gadolinium-based imaging contrast agents, including when to hold your dose, what risks are real, and how to talk to your radiology team.
A clinical deep-dive into the pharmacokinetic and pharmacodynamic interaction between oral estradiol and diphenhydramine, covering CYP enzyme overlap, anticholinergic burden, CNS sedation risk, monitoring parameters, and dose-adjustment guidance.
Does drinking alcohol affect your estradiol patch? Learn how alcohol raises estradiol levels, increases clot and cancer risk, and what safe limits look like during transdermal HRT.
A clinically detailed guide to the pharmacokinetic and pharmacodynamic interactions between transdermal estradiol and cannabis, including effects on CYP450 metabolism, sedation risk, and practical dosing guidance prepared by the HealthRX.com Editorial Team.
A guide to the ezetimibe and progesterone HRT interaction, covering mechanism, severity, monitoring parameters, and patient counseling based on primary literature and FDA labeling.
A guide to the levothyroxine and progesterone HRT interaction: mechanism, clinical impact, monitoring, and dose-adjustment recommendations with primary literature citations.
A clinical deep-dive into the losartan and testosterone interaction, covering CYP2C9 pharmacokinetics, blood pressure effects, polycythemia risk, lipid changes, and monitoring protocols for men on TRT.
A clinician-level review of the pharmacokinetic and pharmacodynamic interactions between NMN/NR (nicotinamide mononucleotide/riboside) and estradiol HRT, including mechanism, monitoring, and dosing guidance.
A guide to the pharmacokinetic and pharmacodynamic interactions between oral micronized progesterone (Prometrium) and cannabis, including CNS sedation risk, CYP enzyme overlap, and practical dosing guidance.
A clinician-level review of the CYP3A4-mediated drug interaction between oral micronized progesterone (Prometrium) and simvastatin, covering mechanism, severity, monitoring, dose adjustment, and patient counseling.
A guide to combining sermorelin acetate and testosterone therapy, covering mechanism, safety, monitoring, and dose considerations, with an evidence-status assessment of what is known, plausible, and unproven.
A deep dive into the suvorexant-testosterone drug interaction, covering CYP3A4 metabolism, polycythemia risk, lipid changes, monitoring protocols, and dose-adjustment guidance for TRT patients taking Belsomra.
A guide to testosterone cypionate's perioperative risks, including polycythemia, thromboembolism, hepatic enzyme effects, and drug interactions with anesthetic agents. Includes dosing windows, monitoring protocols, and FAQ.
A guide to the testosterone cypionate and bupropion drug interaction, covering CYP2D6 inhibition, seizure-threshold effects, monitoring parameters, and dose-adjustment strategies.
Testosterone cypionate significantly potentiates warfarin's anticoagulant effect, raising bleeding risk. Learn the mechanism, severity rating, INR monitoring schedule, dose-adjustment strategy, and patient counseling points backed by primary literature.